chr5:76011951:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr5:76,011,951-76,031,595 |
| hg38 | chr5:76,716,126-76,735,770 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.003 | squamous cell carcinoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | carcinosarcoma | NA | BeFree | Detail | |
| 0.002 | Cardiovascular Diseases | NA | GAD | Detail | |
| <0.001 | cerebral infarction | NA | BeFree | Detail | |
| 0.080 | brain ischemia | NA | RGD | Detail | |
| <0.001 | cholestasis | NA | BeFree | Detail | |
| <0.001 | choriocarcinoma | NA | BeFree | Detail | |
| <0.001 | Congenital chromosomal disease | NA | BeFree | Detail | |
| 0.003 | Colonic Neoplasms | NA | BeFree,LHGDN | Detail | |
| <0.001 | colorectal carcinoma | In recent years, the role of long noncoding RNAs (lncRNAs) in cancer is increasi... | BeFree | 25119598 | Detail |
| 0.001 | Coronary Arteriosclerosis | NA | BeFree | Detail | |
| 0.003 | Coronary heart disease | NA | BeFree,GAD | Detail | |
| <0.001 | coronary thrombosis | NA | BeFree | Detail | |
| <0.001 | Mental Depression | NA | BeFree | Detail | |
| <0.001 | depressive disorder | NA | BeFree | Detail | |
| 0.002 | Dwarfism | NA | BeFree | Detail | |
| 0.003 | encephalitis | NA | LHGDN | Detail | |
| 0.003 | endometriosis | NA | BeFree,LHGDN | Detail | |
| 0.120 | Fatty Liver | NA | CTD_human | Detail | |
| <0.001 | gastroesophageal reflux disease | NA | BeFree | Detail | |
| <0.001 | glioblastoma | NA | BeFree | Detail | |
| <0.001 | Glioma | NA | BeFree | Detail | |
| 0.002 | Hemorrhage | NA | GAD | Detail | |
| 0.120 | hepatitis | NA | CTD_human | Detail | |
| <0.001 | hepatitis C | NA | BeFree | Detail | |
| <0.001 | HIV Infections | Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and... | BeFree | 26283733 | Detail |
| 0.083 | Hyperalgesia | NA | LHGDN,RGD | Detail | |
| 0.080 | Hypertensive disease | NA | RGD | Detail | |
| <0.001 | hypoglycemia | NA | BeFree | Detail | |
| <0.001 | Immunologic Deficiency Syndromes | NA | BeFree | Detail | |
| 0.123 | Inflammation | NA | CTD_human,LHGDN | Detail | |
| 0.003 | Inflammatory Bowel Diseases | NA | LHGDN | Detail | |
| <0.001 | influenza | NA | BeFree | Detail | |
| <0.001 | ischemia | NA | BeFree | Detail | |
| <0.001 | Keloid | NA | BeFree | Detail | |
| 0.003 | Premature Obstetric Labor | NA | LHGDN | Detail | |
| <0.001 | leishmaniasis | NA | BeFree | Detail | |
| <0.001 | leukemia | NA | BeFree | Detail | |
| <0.001 | chronic lymphocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
| 0.123 | liver cirrhosis | NA | CTD_human,LHGDN | Detail | |
| <0.001 | Liver neoplasms | NA | BeFree | Detail | |
| <0.001 | Lung diseases | NA | BeFree | Detail | |
| <0.001 | Chronic Obstructive Airway Disease | NA | BeFree | Detail | |
| <0.001 | Lung Neoplasms | NA | BeFree | Detail | |
| <0.001 | Lupus Erythematosus, Systemic | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of stomach | Thrombin conducts epithelial‑mesenchymal transition via protease‑activated recep... | BeFree | 25231630 | Detail |
| <0.001 | medulloblastoma | Coagulation pathway sensors (F3/TF, F2R/PAR-1) are expressed in MB in a subtype-... | BeFree | 25163932 | Detail |
| 0.011 | melanoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | Mesothelioma | The role of PAR1 in mesothelioma progression is just emerging and our observatio... | BeFree | 25364818 | Detail |
| 0.005 | myocardial infarction | NA | BeFree,GAD | Detail | |
| <0.001 | myocarditis | NA | BeFree | Detail | |
| 0.010 | Neoplasm Metastasis | Collectively, our findings established a functional role for thrombin and its ta... | BeFree,LHGDN | 26238780 | Detail |
| 0.120 | Neoplasms, Experimental | NA | CTD_human | Detail | |
| <0.001 | Degenerative polyarthritis | NA | BeFree | Detail | |
| <0.001 | ovarian carcinoma | NA | BeFree | Detail | |
| 0.003 | Pancreatic Neoplasm | NA | BeFree,LHGDN | Detail | |
| <0.001 | Parkinson disease | NA | BeFree | Detail | |
| <0.001 | Peutz-Jeghers syndrome | NA | BeFree | Detail | |
| <0.001 | pneumonia | NA | BeFree | Detail | |
| <0.001 | Prader-Willi syndrome | NA | BeFree | Detail | |
| 0.011 | Prostatic Neoplasms | NA | BeFree,LHGDN | Detail | |
| <0.001 | pulmonary edema | NA | BeFree | Detail | |
| <0.001 | pulmonary emphysema | NA | BeFree | Detail | |
| 0.009 | pulmonary fibrosis | Accumulating evidence shows that protease-activated receptor-1 (PAR-1) plays an ... | BeFree,LHGDN | 24842054 | Detail |
| <0.001 | rhabdomyosarcoma | NA | BeFree | Detail | |
| <0.001 | schizophrenia | NA | BeFree | Detail | |
| <0.001 | systemic scleroderma | NA | BeFree | Detail | |
| <0.001 | Septicemia | The cytoprotective effects are protease activated receptor 1 (PAR-1) and endothe... | BeFree | 25032959 | Detail |
| <0.001 | Spinal Cord Diseases | NA | BeFree | Detail | |
| 0.120 | Stomach Neoplasms | NA | CTD_human | Detail | |
| 0.003 | Cerebrovascular accident | NA | BeFree,LHGDN | Detail | |
| <0.001 | Turner syndrome | NA | BeFree | Detail | |
| <0.001 | Virus Diseases | NA | BeFree | Detail | |
| <0.001 | Hermanski-Pudlak Syndrome | NA | BeFree | Detail | |
| <0.001 | Polyendocrinopathies, Autoimmune | NA | BeFree | Detail | |
| <0.001 | Squamous cell carcinoma of lung | NA | BeFree | Detail | |
| 0.002 | Premature Birth | NA | GAD | Detail | |
| <0.001 | Arterial thrombosis | NA | BeFree | Detail | |
| <0.001 | lingual-facial-buccal dyskinesia | NA | BeFree | Detail | |
| <0.001 | Idiopathic pulmonary hypertension | NA | BeFree | Detail | |
| <0.001 | Madelung Deformity | NA | BeFree | Detail | |
| <0.001 | Cicatrix, Hypertrophic | NA | BeFree | Detail | |
| 0.002 | Tumor Progression | In recent years, the role of long noncoding RNAs (lncRNAs) in cancer is increasi... | BeFree | 25119598 | Detail |
| <0.001 | cholangiocarcinoma | NA | BeFree | Detail | |
| <0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| <0.001 | Fibrosis, Liver | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of lung | This study suggested that the PTEN/PI3K/AKT signaling pathway plays an important... | BeFree | 25861627 | Detail |
| <0.001 | Proliferative vitreoretinopathy | The purpose of this study was to identify interacting signaling pathways by whic... | BeFree | 26247679 | Detail |
| 0.004 | Sepsis | The cytoprotective effects are protease activated receptor 1 (PAR-1) and endothe... | BeFree,LHGDN | 25032959 | Detail |
| <0.001 | carotid artery occlusion | NA | BeFree | Detail | |
| 0.003 | Leri-Weill dyschondrosteosis | NA | BeFree | Detail | |
| <0.001 | Cholestasis of pregnancy | This study suggested that overexpression of ERp29 may play a key role in TCA-ind... | BeFree | 24780196 | Detail |
| 0.002 | Metastatic melanoma | The present finding uncovers a novel role of MDA-9/syntenin as an important TF·F... | BeFree | 25505176 | Detail |
| <0.001 | Squamous cell carcinoma of esophagus | Our results indicate that the expression of PAR1 and PAR2 in esophageal squamous... | BeFree | 25297082 | Detail |
| <0.001 | Adenocarcinoma Of Esophagus | NA | BeFree | Detail | |
| <0.001 | Vascular Neoplasms | Triggering tissue factor (F3/TF) and thrombin receptors (F2R/PAR-1) may influenc... | BeFree | 25163932 | Detail |
| <0.001 | Restenosis | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of colon | Collectively, our findings established a functional role for thrombin and its ta... | BeFree | 26238780 | Detail |
| <0.001 | Helicobacter-associated gastritis | Protease-activated receptor 1 suppresses Helicobacter pylori gastritis via the i... | BeFree | 24866378 | Detail |
| 0.120 | Platelet mean volume finding | NA | GWASCAT | Detail | |
| <0.001 | Adenoma of lung | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| <0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
| <0.001 | Idiopathic crescentic glomerulonephritis | NA | BeFree | Detail | |
| <0.001 | Chronic rejection of renal transplant | NA | BeFree | Detail | |
| <0.001 | Langer mesomelic dysplasia syndrome | NA | BeFree | Detail | |
| <0.001 | Nephrotic range proteinuria | NA | BeFree | Detail | |
| <0.001 | endometrial carcinoma | NA | BeFree | Detail | |
| <0.001 | Sleep Apnea, Obstructive | NA | BeFree | Detail | |
| <0.001 | Recurrent tumor | NA | BeFree | Detail | |
| 0.003 | Hepatitis C, Chronic | NA | BeFree,LHGDN | Detail | |
| <0.001 | Carcinogenesis | NA | BeFree | Detail | |
| <0.001 | schizophrenia | While further research into the molecular mechanisms underlying this interaction... | BeFree | 19352591 | Detail |
| <0.001 | Leukemogenesis | NA | BeFree | Detail | |
| 0.002 | prostate carcinoma | NA | BeFree | Detail | |
| <0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
| 0.003 | breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinoma of lung | This study suggested that the PTEN/PI3K/AKT signaling pathway plays an important... | BeFree | 25861627 | Detail |
| <0.001 | Tardive Dyskinesia | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
| <0.001 | colon carcinoma | Activation of platelet protease-activated receptor-1 induces epithelial-mesenchy... | BeFree | 25846512 | Detail |
| 0.002 | stomach carcinoma | Thrombin conducts epithelial‑mesenchymal transition via protease‑activated recep... | BeFree | 25231630 | Detail |
| <0.001 | 5q-syndrome | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of kidney | NA | BeFree | Detail | |
| <0.001 | Poorly differentiated carcinoma | Combined with clinical data, the expression of PAR1 in poorly differentiated (P=... | BeFree | 25297082 | Detail |
| <0.001 | Cholestasis, chronic | NA | BeFree | Detail | |
| <0.001 | gastritis h pylori | Using chimeric mice, we demonstrated that PAR1-mediated protection against H. py... | BeFree | 24866378 | Detail |
| <0.001 | malignant pleural mesothelioma | Altered protease-activated receptor-1 expression and signaling in a malignant pl... | BeFree | 25364818 | Detail |
| <0.001 | Helicobacter pylori infection | PAR1 suppression of IRF5 and IL-12/23 secretion by macrophages provides a novel ... | BeFree | 24866378 | Detail |
| <0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Rhabdoid Tumor of the Kidney | Proteinase-activated receptor 1- and 4-promoted migration of Hep3B hepatocellula... | BeFree | 25373316 | Detail |
| <0.001 | Cholestatic liver disease | NA | BeFree | Detail | |
| <0.001 | Cerebral Ischemia | NA | BeFree | Detail | |
| <0.001 | Ischemic stroke | The cytoprotective effects are protease activated receptor 1 (PAR-1) and endothe... | BeFree | 25032959 | Detail |
| <0.001 | Ischemic stroke | Collectively, this study reveals the importance of APC glycosylation in controll... | BeFree | 26084674 | Detail |
| <0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
| <0.001 | attention deficit hyperactivity disorder | NA | BeFree | Detail | |
| <0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
| <0.001 | Myelodysplastic Syndrome with Isolated del(5q) | NA | BeFree | Detail | |
| <0.001 | Partial Trisomy | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of large intestine | NA | BeFree | Detail | |
| <0.001 | Epithelioma | NA | BeFree | Detail | |
| <0.001 | renal carcinoma | NA | BeFree | Detail | |
| <0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
| <0.001 | colorectal cancer | In recent years, the role of long noncoding RNAs (lncRNAs) in cancer is increasi... | BeFree | 25119598 | Detail |
| 0.080 | brain edema | NA | RGD | Detail | |
| 0.002 | Fibrinogen Adverse Event | NA | GAD | Detail | |
| <0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
| <0.001 | Severe Sepsis | NA | BeFree | Detail | |
| <0.001 | Idiopathic Pulmonary Fibrosis | NA | BeFree | Detail | |
| <0.001 | Chromosome 5, trisomy 5q | NA | BeFree | Detail | |
| <0.001 | OVERLAP CONNECTIVE TISSUE DISEASE | Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing t... | BeFree | 25460576 | Detail |
| 0.003 | Venous thromboembolism | NA | LHGDN | Detail | |
| <0.001 | uterine corpus cancer | NA | BeFree | Detail | |
| <0.001 | coronary artery disease | NA | BeFree | Detail | |
| 0.004 | liver carcinoma | We have previously shown that PAR1 and PAR4 are able to promote the migration of... | BeFree,LHGDN | 25373316 | Detail |
| <0.001 | Chronic thromboembolic pulmonary hypertension | NA | BeFree | Detail | |
| 0.003 | Prostatic Hyperplasia | NA | LHGDN | Detail | |
| <0.001 | thyroid hormone resistance syndrome | NA | BeFree | Detail | |
| <0.001 | Refractory anemia, without ringed sideroblasts, without excess blasts | NA | BeFree | Detail | |
| <0.001 | Idiopathic pulmonary arterial hypertension | NA | BeFree | Detail | |
| <0.001 | Ischemic Cerebrovascular Accident | The cytoprotective effects are protease activated receptor 1 (PAR-1) and endothe... | BeFree | 25032959 | Detail |
| <0.001 | Ischemic Cerebrovascular Accident | Collectively, this study reveals the importance of APC glycosylation in controll... | BeFree | 26084674 | Detail |
| 0.003 | Infection | NA | LHGDN | Detail | |
| <0.001 | Congenital Abnormality | NA | BeFree | Detail | |
| <0.001 | Alzheimer's disease | NA | BeFree | Detail | |
| <0.001 | Refractory anemias | NA | BeFree | Detail | |
| <0.001 | arteriosclerosis | NA | BeFree | Detail | |
| <0.001 | rheumatoid arthritis | NA | BeFree | Detail | |
| <0.001 | asthma | NA | BeFree | Detail | |
| <0.001 | atherosclerosis | NA | BeFree | Detail | |
| <0.001 | Autoimmune Diseases | NA | BeFree | Detail | |
| <0.001 | Blood Coagulation Disorders | NA | BeFree | Detail | |
| <0.001 | Bone Marrow Diseases | NA | BeFree | Detail | |
| <0.001 | borderline personality disorder | NA | BeFree | Detail | |
| 0.003 | Malignant neoplasm of breast | NA | BeFree | Detail | |
| <0.001 | Malignant tumor of colon | Activation of platelet protease-activated receptor-1 induces epithelial-mesenchy... | BeFree | 25846512 | Detail |
| <0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
| <0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail | |
| <0.001 | renal cell carcinoma | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In recent years, the role of long noncoding RNAs (lncRNAs) in cancer is increasingly focused. ncRuPA... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Converta... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Thrombin conducts epithelial‑mesenchymal transition via protease‑activated receptor‑1 in human gastr... | DisGeNET | Detail |
| Coagulation pathway sensors (F3/TF, F2R/PAR-1) are expressed in MB in a subtype-specific manner, and... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The role of PAR1 in mesothelioma progression is just emerging and our observations can promote furth... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Collectively, our findings established a functional role for thrombin and its targets PAR-1 and fibr... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Accumulating evidence shows that protease-activated receptor-1 (PAR-1) plays an important role in th... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The cytoprotective effects are protease activated receptor 1 (PAR-1) and endothelial protein C recep... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In recent years, the role of long noncoding RNAs (lncRNAs) in cancer is increasingly focused. ncRuPA... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This study suggested that the PTEN/PI3K/AKT signaling pathway plays an important role in thrombin/PA... | DisGeNET | Detail |
| The purpose of this study was to identify interacting signaling pathways by which the activation of ... | DisGeNET | Detail |
| The cytoprotective effects are protease activated receptor 1 (PAR-1) and endothelial protein C recep... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This study suggested that overexpression of ERp29 may play a key role in TCA-induced apoptosis in HT... | DisGeNET | Detail |
| The present finding uncovers a novel role of MDA-9/syntenin as an important TF·FVIIa·Xa/PAR-1-regula... | DisGeNET | Detail |
| Our results indicate that the expression of PAR1 and PAR2 in esophageal squamous cell carcinoma is i... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Triggering tissue factor (F3/TF) and thrombin receptors (F2R/PAR-1) may influence the vascular tumor... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Collectively, our findings established a functional role for thrombin and its targets PAR-1 and fibr... | DisGeNET | Detail |
| Protease-activated receptor 1 suppresses Helicobacter pylori gastritis via the inhibition of macroph... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| While further research into the molecular mechanisms underlying this interaction is needed, our resu... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This study suggested that the PTEN/PI3K/AKT signaling pathway plays an important role in thrombin/PA... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Activation of platelet protease-activated receptor-1 induces epithelial-mesenchymal transition and c... | DisGeNET | Detail |
| Thrombin conducts epithelial‑mesenchymal transition via protease‑activated receptor‑1 in human gastr... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Combined with clinical data, the expression of PAR1 in poorly differentiated (P=0.016) and middle an... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Using chimeric mice, we demonstrated that PAR1-mediated protection against H. pylori gastritis requi... | DisGeNET | Detail |
| Altered protease-activated receptor-1 expression and signaling in a malignant pleural mesothelioma c... | DisGeNET | Detail |
| PAR1 suppression of IRF5 and IL-12/23 secretion by macrophages provides a novel mechanism by which t... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Proteinase-activated receptor 1- and 4-promoted migration of Hep3B hepatocellular carcinoma cells de... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The cytoprotective effects are protease activated receptor 1 (PAR-1) and endothelial protein C recep... | DisGeNET | Detail |
| Collectively, this study reveals the importance of APC glycosylation in controlling the efficacy of ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In recent years, the role of long noncoding RNAs (lncRNAs) in cancer is increasingly focused. ncRuPA... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We have previously shown that PAR1 and PAR4 are able to promote the migration of hepatocellular carc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The cytoprotective effects are protease activated receptor 1 (PAR-1) and endothelial protein C recep... | DisGeNET | Detail |
| Collectively, this study reveals the importance of APC glycosylation in controlling the efficacy of ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Activation of platelet protease-activated receptor-1 induces epithelial-mesenchymal transition and c... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386602276 dbSNP
- Genome
- hg19
- Position
- chr5:76,011,951-76,031,595
- Variant Type
- snv
Genome browser